Hussman Strategic Advisors Exits Entire TG Therapeutics Stake

lunes, 2 de febrero de 2026, 6:23 pm ET1 min de lectura
TGTX--

Hussman Strategic Advisors sold its entire position in TG Therapeutics, disposing of 126,000 shares. The stake previously represented 1% of the fund's AUM. Top holdings include Qualcomm, Etsy, and United Internet. TG Therapeutics is a biotechnology company specializing in therapies for B-cell malignancies and autoimmune diseases. Its shares have underperformed compared to major indexes, losing 11.8% over the last year.

Hussman Strategic Advisors Exits Entire TG Therapeutics Stake

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios